the target only if they bump into embedded chemosensor that involves the it due to Brownian motion. modulation of hSGLT3 protein Follow gradient: nanorobots glucosensor activity.Through its onboard monitor concentration intensity chemical sensor, the nanorobot can thus for E-cadherin signals, when effectively determine if the patient needs detected, measure and follow the to inject insulin or take any further gradient until reaching the target. action, such as any medication clinically Follow gradient with attractant: prescribed. The image of the NCD Thus, a higher gradient of signal simulator workspace shows the inside intensity of E-cadherin is used as view of a venule blood vessel with grid chemical parameter identification in texture, red blood cells (RBCs) and guiding nanorobots to identify malignant nanorobots. tissues. Integrated nanosensors can be They flow with the RBCs through the used for this. bloodstream detecting the glucose levels. Nanorobots in the Diagnosis and At a typical glucose concentration, the nanorobots try to keep the glucose levels Treatment of Diabetes ranging around 130 mg/dl for the Blood Glucose carried through the blood Glucose Levels (BGLs). In the medical stream is important to maintain the nanorobot architecture, the significant measured data can be then transferred human metabolism working healthfully, automatically through the RF signals to and its correct level is a key issue in the the mobile phone carried by the patient. diagnosis and treatment of diabetes. The most interesting aspect of the protein At any time, if the glucose achieves hSGLT3 is the fact that it serves as a critical levels, the nanorobot emits an sensor to identify glucose. alarm through the mobile phone. The simulated nanorobot prototype model has embedded Complementary Metal Oxide semi-conductor (CMOS) Controlling Glucose Level using nanobioelectronics. It features a size of Nanorobots ~2 micronmeter, which permits it to operate freely inside the body. For the glucose monitoring the nanorobot uses
the target only if they bump into it due to Brownian motion. Follow gradient: nanorobots monitor concentration intensity for E-cadherin signals, when detected, measure and follow the gradient until reaching the target. Follow gradient with attractant: Thus, a higher gradient of signal intensity of E-cadherin is used as chemical parameter identification in guiding nanorobots to identify malignant tissues. Integrated nanosensors can be used for this. Nanorobots in the Diagnosis and Treatment of Diabetes Glucose carried through the blood stream is important to maintain the human metabolism working healthfully, and its correct level is a key issue in the diagnosis and treatment of diabetes. The most interesting aspect of the protein hSGLT3 is the fact that it serves as a sensor to identify glucose. The simulated nanorobot prototype model has embedded Complementary Metal Oxide semi-conductor (CMOS) nanobioelectronics. It features a size of ~2 micronmeter, which permits it to operate freely inside the body. For the glucose monitoring the nanorobot uses embedded chemosensor that involves the modulation of hSGLT3 protein glucosensor activity.Through its onboard chemical sensor, the nanorobot can thus effectively determine if the patient needs to inject insulin or take any further action, such as any medication clinically prescribed. The image of the NCD simulator workspace shows the inside view of a venule blood vessel with grid texture, red blood cells (RBCs) and nanorobots. They flow with the RBCs through the bloodstream detecting the glucose levels. At a typical glucose concentration, the nanorobots try to keep the glucose levels ranging around 130 mg/dl for the Blood Glucose Levels (BGLs). In the medical nanorobot architecture, the significant measured data can be then transferred automatically through the RF signals to the mobile phone carried by the patient. At any time, if the glucose achieves critical levels, the nanorobot emits an alarm through the mobile phone. Controlling Glucose Level using Nanorobots